Anticardiolipin antibody-associated stroke after liver transplantation

Transplantation

Volumn 63, Issue 6, 1997, Pages 908-909

  Bronster, David J ^a   Gousse, Ralph ^a   Passas, Athanasios ^a   Rand, Jacob H ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Box 1079 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CYCLOSPORIN; TACROLIMUS;

ADULT; ANTIBODY DETECTION; ANTICOAGULATION; ARTICLE; CASE REPORT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STROKE;

EID: 0030892256     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703270-00020     Document Type: Article

References (13)

1. Bronster DJ, Emre S, Mor E, Sheiner P, Miller CM, Schwartz ME. Neurologic complications of orthotopic liver transplantation. Mt Sinai J Med 1994; 61: 63.
2. Menegaux F, Keeffe EB, Andrews BT, et al. Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation 1994; 58: 447.
3. APASS Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 1993; 43: 2069.
4. Feldmann E, Levine SR. Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance and therapeutic options. Ann Neurol 1995; 37 (suppl 1): S114.
5. Lockshin MD. Antiphospholipid antibody syndrome. JAMA 1992; 268: 141.
6. Estol CJ, Pessin MS, Martinez AJ. Cerebrovascular complications after orthotopic liver transplantation: a clinicopathologic study. Neurology 1991; 41: 815.
7. Starzl TE, Schneck SA, Mazzoni G, et al. Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg 1978; 187: 236.
8. DeWolf AM, Gologorsky E, Scott V, et al. Intravascular and intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in six patients undergoing liver transplantation. Liver Trans Surg 1995; 1: 416.
9. Malia RG, Kitchen S, Greaves M, et al. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990; 76: 101.
10. Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986; 137: 1532.
11. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993.
12. Harris EN, Boey ML, Mackworth-Young CG, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211
13. Talenti DA, Falk GW, Carey WD, Marchant K. Anticardiolipin antibody-associated cerebral infarction in cirrhosis: clearance of anticardiolipin antibody after liver transplantation. Am J Gastroenterol 1994; 89: 785.